Picture of Fresenius Medical Care AG logo

FME — Fresenius Medical Care AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

FMC falls after Barclays cuts to 'underweight' on earnings concerns

BUZZ-FMC falls after Barclays cuts to 'underweight' on earnings concerns

** Shares in Fresenius Medical Care AG FMEG.DE fall around 3% in early Frankfurt trade after Barclays cut its rating on the dialysis group to "underweight" from "equal weight"

** It cites concerns over earnings outlook due to reimbursement pressure, treatment growth and inflation

** The broker sees "meaningful downside risk" to FMC's medium-term targets, forecasting a 3% EBIT decline over 2025-2028 versus management's 3%-7% growth target

** The downgrade follows FMC's third-quarter results on Tuesday, when the company trimmed the upper end of its 2026 operating income outlook as US treatment volumes continued to fall

** Barclays also flags a potential selldown by Fresenius FREn.DE, which still owns a 25% stake in FMC, as a risk

** It cuts its PT on the stock to €35 from €44.50; shares were up 3.6% year-to-date at Friday's close


($1 = 0.8961 euros)


(Reporting by Kira Britten)

((Kira.Britten@thomsonreuters.com))

Recent news on Fresenius Medical Care AG

See all news